Trial in progress: a phase 2, multicenter, single-arm study of zanubrutinib (BGB-3111) in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma intolerant of prior treatment with ibrutinib

 ABSTRACT   06/2020

For more information about this resource, please submit a medical information request.

Rating

Rate this resource